Patent Assignment
Reel/Frame 076003/0666
Security Interest
Recorded: 2026-09-14
Pages: 9
Assignor
MADRIGAL PHARMACEUTICALS, INC.
Executed: 2026-09-11
Assignee
LSI FINANCING LLC, AS ADMINISTRATIVE AGENT
C/O BLUE OWL CAPITAL CORPORATION, 399 PARK AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(5)
Solid Forms of 2-(3,5-Dichloro-4-((5-Isopropyl-6-Oxo-1,6-Dihydropyridazin-3-Yl)Oxy)Phenyl)-3,5-Dioxo-2,3,4,5-Tetrahydro-1,2,4-Triazine-6-Carbonitrile
Application:
19/303,585 →
Publication:
US US20250368626A1
Resmetirom Therapy of MASH-Associated Child Pugh A Cirrhosis
Application:
63/875,184 →
Resmetirom for Reducing Liver Volume
Methods for Treating a Fatty Liver Disease
Methods for Treating Cardiomyopathy and/or Related Heart Failure and Portal Hypertension
PCT:
PCT/US2025/055116 ↗
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.